Early Access

10-QPeriod: Q1 FY2010

Trane Technologies plc Quarterly Report for Q1 Ended Mar 31, 2010

Filed May 7, 2010For Securities:TT

Summary

Trane Technologies plc (formerly Ingersoll-Rand plc) reported mixed financial results for the first quarter ended March 31, 2010. Net revenues saw a modest increase of 0.7% year-over-year, primarily driven by favorable currency impacts, though this was partially offset by lower volumes and a $14.7 million negative impact from the devaluation of the Venezuelan Bolivar. The company demonstrated improved operational efficiency, with cost of goods sold and selling and administrative expenses decreasing as a percentage of revenue, leading to a significant improvement in operating income to $133.5 million from $49.9 million in the prior year period. Despite the operational improvements, the company recorded a net loss attributable to Ingersoll-Rand plc of $1.4 million, compared to a loss of $26.7 million in the prior year. This was largely due to a substantial $54.0 million provision for income taxes, which included a $40.5 million non-cash charge related to new healthcare reform legislation. Discontinued operations also contributed a loss of $10.4 million. The company is actively managing its debt, with total debt decreasing and a focus on maintaining liquidity through its credit facilities and cash on hand.

Financial Statements
Beta
Revenue$2.77B
Cost of Revenue$2.01B
Gross Profit$756.70M
SG&A Expenses$617.20M
Operating Income$139.50M
Interest Expense$71.00M
Net Income$1.40M
Shares Outstanding (Basic)322.70M
Shares Outstanding (Diluted)336.60M

Key Highlights

  • 1Net revenues increased by 0.7% to $2,953.4 million, primarily due to favorable currency exchange rates.
  • 2Operating income significantly improved to $133.5 million from $49.9 million in the prior year, driven by productivity gains and cost efficiencies.
  • 3Net loss attributable to shareholders was $1.4 million, a substantial improvement from the $26.7 million loss in the first quarter of 2009.
  • 4The company recorded a $40.5 million non-cash charge in income tax expense related to the Patient Protection and Affordable Care Act.
  • 5Total debt decreased to $3,931.3 million from $4,096.6 million at the end of 2009.
  • 6Cash and cash equivalents decreased to $599.1 million from $876.7 million at the end of 2009.
  • 7Restructuring charges for the period were $10.4 million, indicating ongoing efforts to streamline operations.

Frequently Asked Questions